Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,729,680
-
Total 13F shares
-
20,711,886
-
Share change
-
+10,542,261
-
Total reported value
-
$48,449,935
-
Put/Call ratio
-
10%
-
Price per share
-
$2.34
-
Number of holders
-
98
-
Value change
-
+$25,433,676
-
Number of buys
-
46
-
Number of sells
-
54
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q3 2025
As of 30 Sep 2025,
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,711,886 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Boxer Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.